WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

More than 25 Years of Archived Biomedical and Pharmacological Records Acessible in Electronic Format

Details
Research
01 November 2007
Thomson CorporationThomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced that it has added EMBASE® Classic to the Dialog® (File 772) and DataStar® (EM73, EMXX) platforms, providing access to more than 25 years of archived life sciences data available for the first time in electronic format.
Read more ...

EUR 5.2 million for Belgian drug research

Details
Research
22 October 2007
The Belgian drug discovery company Galapagos has been awarded a total of €5.2 million in grants from the Netherlands and the European Union for several drug development projects. The aim is to create candidate drugs for conditions such as bone and joint disease, as well as novel cancer drugs.
Read more ...

EU project improves ability to predict outcome of HIV treatment

Details
Research
22 October 2007
European and Israeli researchers are working together on the development of a clinical management system for the use of drugs and drug combinations given to HIV patients, as part of an EU-funded project.
Read more ...

European Medicines Agency sees strong level of applications in 2007

Details
Research
17 October 2007
European Medicines AgencyThe number of applications for marketing authorisations submitted to the European Medicines Agency (EMEA) remains strong according to the half-year report presented to the Agency's Management Board by Thomas Lönngren, EMEA Executive Director, at its 4 October 2007 meeting.
Read more ...

WWW goes WWWW: Searching is now sorted! The Web 2.0 for real

Details
Research
15 October 2007
Transinsight, provider of knowledge-based software solutions, has released a new online version of the well-known life-science search engine www.GoPubMed.org. This, the first semantic search engine, reduces search time by up to 90%. By sorting search results it enables scientists to answer biomedical questions in completely new way.
Read more ...

European Consumers Seeking Health and Pharmaceutical Information

Details
Research
14 October 2007
Manhattan ResearchEuropean consumers have been a long-neglected piece of the strategic puzzle for most marketers at health and pharmaceutical companies. Yet signs increasingly point to the degree to which European consumers are, in fact, researching health information and treatment options, and ultimately taking action as a result of those information searches.
Read more ...

Life Science Platform Promotes True Scientific Collaboration

Details
Research
10 October 2007
SyynX Solutions GmbHCollexis (OTCBB: CLXS), a leading developer of high-definition search and discovery software, and their German partner, SyynX Solutions, announced they will preview a new life sciences social networking site to representatives from global book publishing and multimedia companies at the Frankfurt Book Fair in Frankfurt, Germany.
Read more ...

More Pharma News ...

  1. Integrated RSS Management Solution Simplifies Information Management and Delivery
  2. European Medicines Agency recommends restricted use of nimesulide-containing medicinal products
  3. New EU Project to Develop a Novel Pandemic Influenza Vaccine
  4. Launch of a broad public debate on the future of pharmaceuticals for human use in Europe
  5. Scientists discover how brain regulates fat metabolism
  6. New Awards Program Focused on Cardiovascular Risk in Patients with Diabetes
  7. ASCO Journals to be accessible through SIMID® S.M.I.L.E.
  • Start
  • Prev
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • 271
  • Next
  • End
Health data interoperability: Opportunities and threats

Business & Industry

  • Valneva switches focus to bilateral discussions to supply its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001
  • Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY®
  • Amgen successfully completes acquisition of Five Prime Therapeutics
  • GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19
  • Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%

Research & Development

  • Differing immune responses discovered in asymptomatic cases vs those with severe COVID-19
  • Patients who are obese or overweight are at risk for a more severe course of COVID-19
  • New COVID-19 vaccine may offer broad protection from coronaviruses
  • SARS-CoV-2: New findings on the persistence of neutralizing antibodies
  • Massive fragment screen points way to new SARS-CoV-2 inhibitors
  • B.1.1.7. variant more transmissible, does not increase severity, Lancet studies suggest
  • COVID-19 causes 'unexpected' cellular response in the lungs

Conferences & Events

  • Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
  • CPhI Worldwide to return in 2021
  • Reuters Events' Cell & Gene Therapy USA
  • Total health: Build a better healthcare system
  • Don't fall for the 'next best action' trap
  • Locking down shape-shifting spike protein aids development of COVID-19 vaccine
  • COVID-19 vaccine innovation could dramatically speed up worldwide production

Regulatory Affairs

  • FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
  • Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
  • AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
  • Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
  • EMA's safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events
  1. You are here:  
  2. Home
  3. Research
  4. Differing immune responses discovered in asymptomatic cases vs those with severe COVID-19

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2021. All Rights Reserved.